Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Artificial Intelligence Algorithm

Related Conditions

Often studied with 5 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Unknown1
Withdrawn1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT05187923Unknown

Computer Aided Tool for Diagnosis of Neck Masses in Children

NCT02061735CompletedPrimary

Ontogeny of Infantile Hemangiomas With Skin Imaging Modalities

NCT01408056Phase 2WithdrawnPrimary

Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)

Showing all 3 trials

Research Network

Common Treatments

  • Artificial Intelligence Algorithm1
  • Mupirocin1

Active Sponsors

  • Society for Pediatric Dermatology2
  • West China Hospital1
  • Children's Hospital of Philadelphia1
  • Children's Hospital Medical Center, Cincinnati1

Top Investigators

Related Conditions

  • Neck Mass1
  • Branchial Cleft Anomalies1
  • Dermoid And Epidermoid Cysts1
  • Teratomas1
  • Thyroglossal Duct Cysts1

Activity Timeline